| Literature DB >> 27957117 |
Maria L Narducci1, Teresa Rio1, Francesco Perna1, Domenico D'Amario1, Biagio Merlino2, Riccardo Marano2, Gianluigi Bencardino1, Frediano Inzani3, Gemma Pelargonio1, Filippo Crea1.
Abstract
In patients with myocarditis, early diagnosis and appropriate therapy are mandatory, as well as close clinical follow-up with particular regard to progression of disease and ventricular arrhythmia recurrences. The management of ventricular arrhythmias should follow current guidelines for ICD implantation, but new therapeutic options could be evaluated in these patients, such as combined epicardial/endocardial ablation and external wearable defibrillator. Particularly, depressed left ventricular ejection fraction (LVEF) represents the only risk marker for sudden cardiac death currently used in myocarditis, although the use of a single risk factor has limited utility. On this regard, combined analysis of myocardial tissue structure by cardiac magnetic resonance (CMR) and endomyocardial biopsy, in association with resting cardiac systolic function, could improve predictive accuracy for SCD in patients with myocarditis.Entities:
Year: 2014 PMID: 27957117 PMCID: PMC4956286 DOI: 10.4022/jafib.1121
Source DB: PubMed Journal: J Atr Fibrillation ISSN: 1941-6911